These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17277852

  • 1. [Early steroid withdrawal in pediatric renal transplantation].
    Delucchi B A, Valenzuela A M, Ferrario B M, Lillo D AM, Guerrero G JL, Rodríguez S E, Cano Sch F, Cavada Ch G, Godoy L J, Rodríguez H J, González G G, Buckel B E, Contreras M L.
    Rev Med Chil; 2006 Nov; 134(11):1393-401. PubMed ID: 17277852
    [Abstract] [Full Text] [Related]

  • 2. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E.
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [Abstract] [Full Text] [Related]

  • 3. Early steroid withdrawal in pediatric renal transplantation at a single center: preliminary report.
    Valenzuela M, Delucchi A, Ferrario M, Lillo AM, Guerrero JL, Rodríguez E, Cano F, Cavada G.
    Transplant Proc; 2008 Nov; 40(9):3237-40. PubMed ID: 19010242
    [Abstract] [Full Text] [Related]

  • 4. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 5. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 20; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 6. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G.
    Transpl Int; 2005 Jan 20; 18(1):36-42. PubMed ID: 15612981
    [Abstract] [Full Text] [Related]

  • 7. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
    Nematalla AH, Bakr MA, Gheith OA, Elagroudy AE, Elshahawy el-M, Aghoneim M.
    Exp Clin Transplant; 2007 Dec 20; 5(2):673-9. PubMed ID: 18194120
    [Abstract] [Full Text] [Related]

  • 8. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradszky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Kalmar KN, Hickey D.
    Transpl Int; 2005 Feb 20; 18(2):157-62. PubMed ID: 15691267
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL, Fan ST, Lo CM, Chan SC, Ng IO, Lai CL, Wong J.
    Liver Transpl; 2004 Jun 20; 10(6):728-33. PubMed ID: 15162466
    [Abstract] [Full Text] [Related]

  • 12. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.
    Miura M, Harada H, Fukuzawa N, Iwami D, Taniguchi A, Seki T, Togashi M, Ogawa Y, Satoh H, Hirano T.
    Clin Transplant; 2005 Jun 20; 19 Suppl 14():54-8. PubMed ID: 15955170
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial.
    Abramowicz D, Vanrenterghem Y, Squifflet JP, Kuypers D, Mourad M, Meurisse M, Wissing M.
    Clin Transplant; 2005 Aug 20; 19(4):475-82. PubMed ID: 16008591
    [Abstract] [Full Text] [Related]

  • 14. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
    Phanish MK, Hull RP, Andrews PA, Popoola J, Kingdon EJ, MacPhee IAM, South West Thames Renal Transplantation Network.
    BMC Nephrol; 2020 Mar 11; 21(1):92. PubMed ID: 32160893
    [Abstract] [Full Text] [Related]

  • 15. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O.
    Transplantation; 2003 Nov 15; 76(9):1331-9. PubMed ID: 14627912
    [Abstract] [Full Text] [Related]

  • 16. Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.
    Budde K, Bosmans JL, Sennesael J, Zeier M, Pisarski P, Schütz M, Fischer W, Neumayer HH, Glander P.
    Clin Nephrol; 2007 Mar 15; 67(3):164-75. PubMed ID: 17390741
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.
    Health Technol Assess; 2005 May 15; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [Abstract] [Full Text] [Related]

  • 19. Early steroid withdrawal in adult kidney transplantation at a single center.
    Iwamoto H, Hama K, Konno O, Yokoyama T, Kihara Y, Jojima Y, Nakamura Y, Takeuchi H, Shimazu M.
    Transplant Proc; 2012 Jan 15; 44(1):179-81. PubMed ID: 22310609
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G, Toenshoff B, Höcker B, Krauss M, Bulla M, Cochat P, Fehrenbach H, Fischer W, Foulard M, Hoppe B, Hoyer PF, Jungraithmayr TC, Klaus G, Latta K, Leichter H, Mihatsch MJ, Misselwitz J, Montoya C, Müller-Wiefel DE, Neuhaus TJ, Pape L, Querfeld U, Plank C, Schwarke D, Wygoda S, Zimmerhackl LB.
    Transplantation; 2008 Nov 15; 86(9):1241-8. PubMed ID: 19005406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.